fenoldopam has been researched along with Acute Kidney Tubular Necrosis in 4 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenoldopam is a dopamine receptor alpha1-specific agonist that increases renal blood flow in patients with kidney failure." | 2.71 | Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. ( Cotsonis, G; Finkel, KW; Murray, PT; Samuels, J; Shaw, AD; Tumlin, JA, 2005) |
| "Fenoldopam has no dopamine-2, alpha or beta-adrenergic activity and is 3." | 2.41 | [Fenoldopam: potential clinical applications in heart surgery]. ( Shorten, GD, 2001) |
| "Treatment with fenoldopam increased renal blood flow in comparison to that in the control group ( p = 0." | 1.32 | The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. ( Bird, ET; Cohn, EJ; Harlin, SA; Harre, JG; Hogan, MB; Holmes, GF; Miller, ML; Miller, Q; Peyton, BD; Riley, KD; Taylor, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathur, VS | 1 |
| Miller, Q | 1 |
| Peyton, BD | 1 |
| Cohn, EJ | 1 |
| Holmes, GF | 1 |
| Harlin, SA | 1 |
| Bird, ET | 1 |
| Harre, JG | 1 |
| Miller, ML | 1 |
| Riley, KD | 1 |
| Hogan, MB | 1 |
| Taylor, A | 1 |
| Tumlin, JA | 1 |
| Finkel, KW | 1 |
| Murray, PT | 1 |
| Samuels, J | 1 |
| Cotsonis, G | 1 |
| Shaw, AD | 1 |
| Shorten, GD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial[NCT00286403] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2008-08-31 | Withdrawn (stopped due to The study was terminated due to logistics at a local hospital.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fenoldopam and Acute Kidney Tubular Necrosis
| Article | Year |
|---|---|
Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
Topics: Acute Kidney Injury; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Dopamine Agonist | 2001 |
[Fenoldopam: potential clinical applications in heart surgery].
Topics: Acute Kidney Injury; Antihypertensive Agents; Coronary Artery Bypass; Diuretics; Dopamine Agonists; | 2001 |
1 trial available for fenoldopam and Acute Kidney Tubular Necrosis
| Article | Year |
|---|---|
Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Creatinine; Diabetes Complications; Disease Progression; Dopamine Agonists; Double-Blind Method; Ear | 2005 |
1 other study available for fenoldopam and Acute Kidney Tubular Necrosis
| Article | Year |
|---|---|
The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Constriction; Creatinine; Dopamine Agonists; Fenoldo | 2003 |